Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.550
+0.030 (1.19%)
Oct 19, 2026, 4:10 PM AEST
Mayne Pharma Group Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 209 | 227 | 406 | 383 | 367 | 441 | |
Market Cap Growth | -58.48% | -44.20% | 6.16% | 4.25% | -16.81% | -21.88% |
Enterprise Value | 172 | 202 | 321 | 264 | 273 | 717 |
Last Close Price | 2.55 | 2.79 | 5.00 | 4.71 | 4.40 | 4.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 9.41 | 9.26 | - | - | 3.13 | - |
Forward PE | - | 150.33 | 150.33 | 150.33 | 150.33 | 150.33 |
PS Ratio | 0.54 | 0.59 | 1.00 | 0.99 | 2.00 | 2.81 |
PB Ratio | 0.53 | 0.58 | 1.10 | 0.84 | 0.58 | 0.82 |
P/TBV Ratio | - | - | - | - | 19.18 | 3.46 |
P/FCF Ratio | 19.12 | 20.75 | 78.23 | - | - | - |
P/OCF Ratio | 15.06 | 16.35 | 23.25 | - | - | - |
PEG Ratio | - | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.45 | 0.53 | 0.79 | 0.68 | 1.49 | 4.56 |
EV/EBITDA Ratio | 4.75 | 6.09 | 7.63 | - | - | - |
EV/FCF Ratio | 15.75 | 18.47 | 61.85 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.11 | 0.11 | 0.11 | 0.09 | 0.08 | 0.77 |
Debt / EBITDA Ratio | 1.19 | 1.19 | 0.90 | - | - | - |
Debt / FCF Ratio | 3.96 | 3.96 | 7.95 | - | - | - |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.16 | -0.24 | -0.27 | 0.59 |
Net Debt / EBITDA Ratio | -1.11 | -1.11 | -1.40 | 7.62 | 1.48 | -6.81 |
Net Debt / FCF Ratio | -3.37 | -3.37 | -11.39 | 4.75 | 3.38 | -18.34 |
Asset Turnover | 0.40 | 0.40 | 0.38 | 0.33 | 0.14 | 0.11 |
Inventory Turnover | 2.56 | 2.56 | 2.57 | 2.16 | 1.05 | 0.81 |
Quick Ratio | 0.98 | 0.98 | 1.08 | 1.03 | 1.38 | 0.61 |
Current Ratio | 1.31 | 1.31 | 1.35 | 1.33 | 1.78 | 0.81 |
Return on Equity (ROE) | 8.20% | 8.20% | -21.85% | -30.98% | -54.14% | -33.61% |
Return on Assets (ROA) | -1.73% | -1.73% | -1.28% | -4.07% | -9.04% | -5.57% |
Return on Invested Capital (ROIC) | -6.55% | -6.97% | -6.73% | -19.33% | -27.89% | -13.07% |
Return on Capital Employed (ROCE) | -4.10% | -4.10% | -2.90% | -9.80% | -19.60% | -18.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 11.72% | 10.80% | -23.10% | -45.53% | 31.94% | -63.75% |
FCF Yield | 5.23% | 4.82% | 1.28% | -6.08% | -13.91% | -3.90% |
Payout Ratio | - | - | - | - | 38.63% | - |
Buyback Yield / Dilution | -34.30% | -34.30% | 0.60% | 3.11% | 0.15% | -4.74% |